ZOOM First Impressions

February 13, 2023 updated by: Steven H. Dayan, DeNova Research

Effects of Video Conferencing on First Impressions and Attractiveness

Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person.

Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • DeNova Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 39 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Males and females of ages 21-39.
  2. Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.
  3. Subjects must all be able to speak English fluently.
  4. Subjects must have access to video camera technology.
  5. Fully Vaccinated against covid-19

Exclusion Criteria:

  1. Participants younger than 21 or older than 40 will not be included.
  2. Subjects who are pregnant or nursing.
  3. Imprisoned populations.
  4. Subjects who are unable to travel to the clinic.
  5. Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.
  6. Any subject that is not fully vaccinated against covid-19

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zoom meeting (camera off)
participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
Experimental: In person meeting (blindfolded)
Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
Experimental: Zoom meeting (camera on)
participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7
Experimental: In person meeting (no blindfold)
Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.
Visual attractiveness scale 0-7
Self Esteem scale
Trustworthiness scale 0-7

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First Impressions
Time Frame: 8 weeks
The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success. The scale ranges from a score of 1 (less desirable) to 10 (most desirable). Scores closer to 10 signify a more positive outcome.
8 weeks
Trustworthiness scale
Time Frame: 8 weeks
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
8 weeks
Overall Attractiveness
Time Frame: 8 weeks
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Esteem
Time Frame: 8 weeks
The Rosenberg Self-Esteem Scale is a 10-item self-report measure of global self-esteem. It consists of 10 statements related to overall feelings of self-worth or self-acceptance. The items are answered on a four-point scale ranging from strongly agree, agree, disagree, and strongly disagree.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Actual)

October 1, 2022

Study Completion (Actual)

November 1, 2022

Study Registration Dates

First Submitted

April 19, 2022

First Submitted That Met QC Criteria

February 13, 2023

First Posted (Estimate)

February 22, 2023

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ZOOM-SD-2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self Esteem

3
Subscribe